⌘K

Login Start Free

Home/Filings/4/0001264124-06-000270

4//SEC Filing

AMYLIN PHARMACEUTICALS INC 4

Accession 0001264124-06-000270

CIK 0000881464operating

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 10:56 AM ET

Size

13.2 KB

Accession

0001264124-06-000270

Insider Transaction Report

Form 4

Period: 2006-06-01

AMYLIN PHARMACEUTICALS INCAMLN

EBERHARD CRAIG A

VP Sales

Transactions

Exercise/Conversion
Common Stock
2006-06-01$18.85/sh+1,500$28,275→ 23,293 total
Sale
Common Stock
2006-06-01$45.59/sh−1,500$68,385→ 21,793 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2006-06-01−1,500→ 17,800 total
Exercise: $18.85From: 2003-05-12Exp: 2013-05-12→ Common Stock (1,500 underlying)
Sale
Common Stock
2006-06-01$46.64/sh−500$23,320→ 21,793 total
Exercise/Conversion
Common Stock
2006-06-01$18.85/sh+500$9,425→ 22,293 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2006-06-01−500→ 17,300 total
Exercise: $18.85From: 2003-05-12Exp: 2013-05-12→ Common Stock (500 underlying)

Footnotes (1)

[F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AMYLIN PHARMACEUTICALS INC

CIK 0000881464

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000881464

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 10:56 AM ET
Size: 13.2 KB

View on SEC.gov